IMPROVED THERAPEUTIC RATIO WITH PROTRACTED VENOUS INFUSION (PVI) 5-FLUOROURACIL (5FU) DURING POSTOPERATIVE EXTERNAL-BEAM RADIOTHERAPY FOR HIGH-RISK RECTAL-CANCER

被引：4
|
作者：
RICH, T [1 ]
OCONNELL, M [1 ]
MARTENSON, J [1 ]
WIEAND, H [1 ]
KROOK, J [1 ]
MACDONALD, J [1 ]
HALLER, D [1 ]
MAYER, R [1 ]
GUNDERSON, L [1 ]
机构：
[1] N CENT CANC TREATMENT GRP,ROCHESTER,MN
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1993年 / 27卷
关键词：
D O I：
10.1016/0360-3016(93)90821-C
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：245 / 246
页数：2
相关论文
共 18 条
  • [1] Radiotherapy (RT) with intravenous and endolymphatic infusion 5-fluorouracil (5FU) in advanced inoperable rectal cancer
    Bondar, G. V.
    Psaras, G. G.
    Basheev, V. H.
    Zolotukhin, S. E.
    Bulatova, M. A.
    Dolgova, M. V.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 80 - 80
  • [2] Combined radiotherapy, 5-Fluorouracil (5FU) continuous infusion and weekly Oxaliplatin in advanced rectal cancer: Phase I study
    Francois, Eric D.
    Ychou, Marc
    Ducreux, Michel
    Bertheault-Cvitkovic, Frederique
    Giovannini, Marc
    Conroy, Thierry
    Lemansk, Claire
    Thomas, Oliver
    Mari, Veronique
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 96 - 97
  • [3] A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer
    Tebbutt, NC
    Norman, A
    Cunningham, D
    Iveson, T
    Seymour, M
    Hickish, T
    Harper, P
    Maisey, N
    Mochlinski, K
    Prior, I
    Hill, M
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (10) : 1568 - 1575
  • [4] Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer
    Shinchi, H
    Takao, S
    Noma, H
    Matsuo, Y
    Mataki, Y
    Mori, S
    Aikou, T
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (01): : 146 - 150
  • [5] Adjuvant chemoradiation (CRT) for high-risk gastric cancer (GC): Single-center experience using infusional 5-fluorouracil (5FU) and radiotherapy (RT).
    Papademetriou, K.
    Vasiliou, V.
    Kountourakis, P.
    Bagatzounis, A.
    Papamichael, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Adjuvant chemoradiotherapy (CRT) for high-risk gastric cancer (GC) patients: single-center experience using infusional 5-fluorouracil (5FU) and radiotherapy (RT)
    Papadimitriou, K.
    Vassiliou, V.
    Kountourakis, P.
    Polyviou, P.
    Andreopoulos, D.
    Papamichael, D.
    [J]. MEDICAL ONCOLOGY, 2012, 29 (04) : 2716 - 2717
  • [7] Adjuvant chemoradiotherapy (CRT) for high-risk gastric cancer (GC) patients: single-center experience using infusional 5-fluorouracil (5FU) and radiotherapy (RT)
    K. Papadimitriou
    V. Vassiliou
    P. Kountourakis
    P. Polyviou
    D. Andreopoulos
    D. Papamichael
    [J]. Medical Oncology, 2012, 29 : 2716 - 2717
  • [8] A phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer
    Navarro, Matilde
    Dotor, Emma
    Rivera, Fernando
    Sanchez-Rovira, Pedro
    Vega-Villegas, Maria Eugenia
    Cervantes, Andres
    Garcia, Jose Luis
    Gallen, Manel
    Aranda, Enrique
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01): : 201 - 205
  • [9] Neoadjuvant therapy with oxaliplatin (OXA) and 5-fluorouracil (5FU) continuous infusion (CO combined with radiotherapy (RT)in rectal cancer: First results of the Bologna phase II study.
    Pinto, C
    Gentile, AL
    Iacopino, B
    Neri, S
    Ugolini, G
    Minni, F
    Ceccarelli, C
    Martinelli, GN
    Cola, B
    Martoni, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 259S - 259S
  • [10] Protracted venous infusion 5-fluorouracil (PVI 5-FU), subcutaneous (SC) interleukin-2 and alpha-interferon (IFN) in metastatic renal cell cancer: A phase II study.
    Allen, M
    Vaughan, M
    Webb, A
    Johnston, S
    Bate, S
    Moore, J
    Ahern, R
    Gore, M
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 : 67 - 67
12